When switching to once-daily treatment, patients should be given a choice as to the time of treatment to minimise the impact of forgetting a dose.doi:10.2165/00003495-199958004-00001Hyland MEDrugsDrugsHyland ME. Rationale for once-daily therapy in asthma: compliance issues. Drugs 1999; 58Suppl....
Once-daily inhaled budesonide for the treatment of asthma: Clinical ev- idence and pharmacokinetic explanation. Journal of Asthma 2004;41(8):771—90. need to be made relevant, with consensus defi- nitions replacing over-technical terminology. They also need to fit into 'real-life' British ...
Roger - 《Journal of Asthma Official Journal of the Association for the Care of Asthma》 被引量: 98发表: 1992年 Aminophylline in the Treatment of Acute Asthma When \\u00df2-Adrenergics and Steroids Are Provided The focus of this review is the musculoskeletal side effects of . These untoward...
For two decades, asthma treatment for millions of people with a milder form of the disease has consisted of daily inhaled steroid medicine to reduce inflammation. Now, a new study has found that asthmatics who take the low-dose medication as a daily routine do no better than those who turn...
Once-daily dosing offers an effective and convenient treatment that could aid compliance in the treatment of asthma. 展开 关键词: Anti Inflammatory Agents, Steroidal Pregnadienediols Administration, Intranasal Adult Asthma Circadian Rhythm Cosyntropin Dose Response Relationship, Drug Double Blind Method ...
The efficacy and side-effects of individually adjusted doses of controlled-release theophylline given once daily in the evening (average dose 650 mg) were compared with those of standard treatment with controlled-release terbutaline 7.5 mg b.d. Thirty-six asthmatics with regular morning obstruction...
The three treatments produced similar increases in morning PEF (7.1 to 8.3 percent; approximately 32 liters per minute; P=0.90) and similar rates of asthma exacerbations (P=0.24), even though the intermittent-treatment group took budesonide, on average, for only 0.5 week of the year. As ...
Furthermore, inhaled corticosteroids are clinically more effective and improve outcomes to a greater extent than any other asthma drug available for maintenance treatment in patients with mild, persistent asthma.2 5–7 However, the adverse effect on annual growth rates reported in the study of ...
Few studies comparing different treatment options for mild persistent asthma have been done, because of the challenges in enrolling such mild patients and in assessing changes in their clinical course.3–15 MIAMI was a year-long, large, multicenter trial designed to directly compare the level of ...
[1,2] Indacaterol is intended for the long-term maintenance treatment of COPD. It is not to be used for treatment of asthma or sudden acute and severe symptoms of COPD. Similar to all LABAs, indacaterol carries a boxed warning that it may increase the risk of asthma-related deaths.[1,2...